New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 17, 2014
12:35 EDTHSP, CBSTHospira granted tentative approval for generic daptomycin
Hospira (HSP) was granted tentative approval for generic daptomycin, according to a post to the FDA's website dated June 16. Daptomycin is an antibiotic used in the treatment of infections caused by Gram-positive organisms that is sold under the trade name Cubicin by Cubist Pharmaceuticals (CBST). Reference Link
News For HSP;CBST From The Last 14 Days
Check below for free stories on HSP;CBST the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 18, 2014
05:33 EDTCBSTCubist opens international headquarters in Zurich, will invest $400M in R&D
Subscribe for More Information
September 9, 2014
12:15 EDTHSPHospira expects 2015 to be a turnaround year for pump business
Subscribe for More Information
11:57 EDTHSPHospira says it has appealed court's adverse decision relating to Precedex
The argument for appeal has been set for October 27. Comments taken from Morgan Stanley Global Healthcare Conference.
September 8, 2014
12:40 EDTHSPPar Pharmaceutical resumes shipment of generic Precedex Injection
Subscribe for More Information
08:33 EDTHSPHospira confirms FY14 EPS view $2.30-$2.50, consensus $2.41
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use